dr. reddy's labs glp-1 receptor agonist Glucagon-like peptide-1 receptor: mechanisms and advances in therapy Dr Reddy's Enters the GLP-1

For Researchers There is a clear need for future research to examine changes in dietary intake and nutrient status following use of obesity medications using robust study designs with validated, accurate methods for measuring daily habitual intakes

J Biol Regul Homeost Agents

Hermansen K, Kipnes M, Luo E, et al

from 2011 through 2023

Anti-inflammatory effects of GLP-1-Based therapies beyond glucose control

Four published studies showed no pancreatitis effects including one in which the pancreas of rats, mice and monkeys showed no change with liraglutide at concentrations 60 fold higher than used in humans for up to two years (86)